Updates from around the Mölnlycke world
Collaboration is key to our success. Explore what we’re saying, what we’re sharing and what we’re thinking.
Asia Pacific Burn Congress
We are pleased to announce that Mölnlycke will attend the 14 th APBC (Asian Pacific Burn Congress) in Chongqing of China on September 13 - 16, 2023.
ERAS World Congress 2023: Supporting perioperative care
From May 31st to June 2nd, the ERAS Society, which was founded on the mission to develop perioperative care and to improve recovery through research,...
EPUAP 2023 is coming up: Let’s take the pressure off!
Pressure ulcers continue to place a huge burden on both patients and healthcare systems and as long as there's scope to reduce that burden, Mölnlycke wi...
May 5, 2023
Mölnlycke signs a EUR 350 million revolving credit facility
On 28 April 2023, Mölnlycke entered into a new EUR 350 million multicurrency revolving credit facility. The facility has a tenor of five years with two...
March 30, 2023
Mölnlycke publishes its integrated 2022 Annual Report
Mölnlycke’s determination to always put customers and patients first made 2022 another successful year, reaching an organic sales growth of 8.4%. Learn...
March 14, 2023
Aashima Gupta joins Mölnlycke’s Board of Directors
Aashima Gupta, Global Director of Healthcare Industry Solutions at Google Cloud , has been elected Board Member at Mölnlycke AB as of 1 March 2023.
March 10, 2023
The impact of venous leg ulcers on patient quality of life
New Wounds International article focuses on the impact of venous leg ulcers on patient quality of life and looks at considerations for dressings selecti...
March 10, 2023
The Simplified Surgical Site Event Risk Assessment (SSERA) model published on Wounds International
Despite advances in surgical techniques, still today, surgical site complications such as SSI remain a challenge in clinical practice and a significant...
March 3, 2023
Mölnlycke and ENGIE expand partnership on energy transition to reach global net zero
From strategy to implementation, Mölnlycke ® is partnering with ENGIE in our transformation to become a global leader in sustainable healthcare.
February 24, 2023
Mölnlycke supports the European Institution’s effort of using an accelerated process to adopt the proposed amendment to the MDR
Mölnlycke expects to be MDR compliant in line with the original timeline - but supports the proposed extended MDR transition period in order to protect...
December 15, 2022
Changing surgical gloves and instruments significantly reduces surgical site infection (SSI)
Robust global clinical trial included 13,000+ patients; results published in The Lancet
December 14, 2022
Global consensus on incision care and dressing selection in surgical wounds
Incision care has been an area of little focus in the past with a vast majority of patients still being treated the same way today as 50 years ago – wit...
EWMA Milan 3-5 May 2023
EWMA has been the largest European wound care congress for a long time. Now we are entering a new era in which EWMA takes center stage as an important...
Mölnlycke takes a stand for diabetic foot care at ISDF 2023
Lower-extremity and diabetic foot wound care take center stage at International Symposium on the Diabetic Foot (ISDF), The Hauge, 10-13 May 2023
October 13, 2022
Closed Incision Negative Pressure Wound Therapy: A literature review and an introduction to Avance Solo
A supplement, authored by Phil Davies, Senior Global Medical Affairs Manager at Mölnlycke Healthcare, presenting a literature review on Closed Incision...
September 20, 2022
Mölnlycke inaugurates new plant and accelerates to meet future demand for supply and sustainability
In its pursuit of sustainable growth and to meet future demands for supply and sustainability Mölnlycke has inaugurated a new surgical gloves factory in...
September 13, 2022
Mölnlycke Health Care is announced as new Founding Partner for GoCo Arena
Last spring, Mölnlycke Health Care announced that they will move to an entire new headquarter in GoCo Health Innovation City. The 16,000 square meter...
September 1, 2022
Karl-Henrik Sundström appointed Chair of the Board of Mölnlycke
Karl-Henrik Sundström, professional board member and, among others, former CEO of Stora Enso and CFO of Ericsson, has been appointed new Chair of the...
August 30, 2022
Mölnlycke invests EUR 50 million in a new surgical gloves plant to meet future demand on supply and sustainability
Mölnlycke ® is investing EUR 50 million in a new plant in Kulim, Malaysia, to meet future demand for high-quality surgical gloves. The new plant will...
June 22, 2022
Mölnlycke breaks ground for its new headquarters at GoCo Health Innovation City
Today, Mölnlycke joins the groundbreaking ceremony marking the start of construction for their future headquarters at GoCo Health Innovation City. “This...
June 13, 2022
Mölnlycke wins Red Dot Award: Product Design 2022
Facial Pressure Injuries (PI) caused by extended use of medical devices have long been a burden for patients and difficult for health care professionals...
May 3, 2022
Mepilex Ag in the management of partial-thickness burns: A review of the clinical evidence
Pawlak, U., Davies, P., Wounds International 2022
May 2, 2022
Mölnlycke announces price increases
Despite the fact that Mölnlycke has introduced a number of measures, the current global macro-economic challenges are now forcing us to raise prices....
April 12, 2022
Mölnlycke publishes 2021 Annual and Sustainability report
Mölnlycke’s integrated Annual and Sustainability Report is now available for download, outlining the company’s results and performance in 2021.
March 18, 2022
Mölnlycke have been awarded a silver medal for sustainability
The world’s largest and most trusted provider of business sustainability ratings - EcoVadis, has awarded Mölnlycke a silver medal for our focus on...
March 3, 2022
Regarding the tragic events in Ukraine
We are deeply concerned about the current security situation in Europe and fully acknowledge the gravity and tragedy of events in Ukraine. While Mölnlyc...
March 1, 2022
Mölnlycke to relocate HQ to GoCo Health Innovation City
In late 2024 Mölnlycke will relocate to brand new headquarters in GoCo Health Innovation City in Mölndal. The new headquarters will have a total area of...
January 19, 2022
Mölnlycke to advance wound care with new technology
We design and supply medical solutions to enhance performance at every point of care – from the operating room to the home. Now we are gearing up for a...
Navigating the post Covid-19 elective surgery backlog – 12 months on
Watch the recent Mölnlycke Talks Online round table discussion, where we catch up with our expert panel who shares their reflections on events since we...
Navigating the post Covid-19 elective surgery backlog – 12 months on
At Molnlycke, we value making a real, sustainable difference to all patients and healthcare professionals globally. Join us for a round table discussion...
October 14, 2021
Granulox® wins Prix Galien
Mölnlycke’s haemoglobin spray Granulox ® has been awarded the prestigious Prix Galien for best new medical device in Belgium and Luxembourg.
October 7, 2021
Mölnlycke gold sponsor at the 16th Park Annual 2021
Nordic Health Innovation: From realisation to business 16th Park Annual 2021 takes place on October 7, 10:00 – 15:00 CET and can be attended virtually....
July 1, 2021
New structure sets Mölnlycke up for the future
Mölnlycke now moves to a new structure based on business areas, driven from a customer centric perspective with an end-to-end responsibility. At the sam...
May 18, 2021
Ensuring Sweden is prepared for future crises
The industry community is ideally placed to ensure Sweden’s resilience for the future. Saab AB, ABB AB, AB Volvo and Mölnlycke AB are partnering to help...
June 1, 2021
Turning the operating room green: how can we help to make it happen?
Join us for a roundtable discussion on sustainability in the OR and balancing patient and healthcare provider care with care for the environment. Watch...
April 27, 2021
Tina and Daniel volunteer during the Covid crisis
Tina Westerberg and Daniel Tsang work at Mölnlycke´s R&D department. When the Swedish healthcare needed help, they both stepped in.
April 19, 2021
Mölnlycke expands in Malaysia with the construction of a new factory
Last month saw the ground-breaking ceremony for Mölnlycke’s new surgical glove factory in Malaysia. The company is increasing its manufacturing capacity...
April 7, 2021
Mölnlycke publishes 2020 Annual Report
The 2020 report shows the company achieved strong organic sales growth, partly through supplying personal protective equipment (PPE) during the COVID-19...
March 30, 2021
Sustainability Report 2020
The company’s most recent Sustainability Report is out now, outlining our performance against our sustainability targets and approach for the future.
March 26, 2021
Mölnlycke to help establish cleft care centre in the Philippines
World-leading medical solutions company Mölnlycke is setting up a centre for cleft care in the Philippine city of Cebu with its long-term charity partne...
May 11, 2021
How can we keep the burden of wound care from bleeding the system dry? A patient, provider and payer perspective
At Mölnlycke ® , we value connecting with healthcare professionals from around the world. Join us for a roundtable discussion. Watch on-demand
March 16, 2021
Johan Torgeby and Kristina Willgård elected new Board members of Mölnlycke
During an extra general meeting on 16 March 2021, the Board of Mölnlycke appointed Johan Torgeby and Kristina Willgård as new Board members.
February 12, 2021
Mölnlycke establishes new Global Business Service centre in Gothenburg
To support Mölnlycke’s next level of growth, and further develop the way we work in the Finance, IT and People/HR functions, Mölnlycke is establishing a...
February 4, 2021
Mölnlycke volunteers in hospitals during COVID-19
When the Swedish healthcare system sent out an urgent appeal for support with the pandemic, Mölnlycke and its employees sprang into action.
December 15, 2020
Statement on our Supplier Code of Conduct
Mölnlycke has recently been made aware of alleged deviations from our Supplier Code of Conduct by one of our Chinese suppliers. We take these reports ve...
December 7, 2020
Mölnlycke boosts customer supply route with new UK distribution centre
7 December 2020, Milton Keynes, UK. Mölnlycke announces the launch of a new UK distribution centre, strengthening customers’ access to quality Mölnlycke...
December 3, 2020
Successful 10-year Eurobond issue for Mölnlycke
Mölnlycke, a world-leading medical solutions company, successfully launched on 2 of December a EUR 400 million senior unsecured bond under its EMTN (Eur...
November 30, 2020
Zlatko Rihter assumes position as President and CEO of Mölnlycke
Today, Zlatko Rihter assumes his position as President and CEO of Mölnlycke.
Re-opening Operating Theatres: Navigating the post Covid-19 elective surgery backlog
Welcome to our popular Mölnlycke Talks Online - 'Re-opening Operating Theatres: Navigating the post Covid-19 elective surgery backlog. December 1, 19:00...
Pressure injury challenges in a new era
Pressure injuries (PI) continue to present substantial clinical challenges to health care professionals and place a huge economic burden on health care...
October 15, 2020
Mölnlycke launches new skin-friendly Biogel® surgical gloves to reduce the risk of allergic contact dermatitis for surgeons and nurses
Gothenburg, Sweden. 15 October, 2020 – Mölnlycke is celebrating World Handwashing Day with the global launch of the innovative Biogel® PI UltraTouch® S...
November 23, 2020
Covid: a catalyst to improve patient engagement. Rethink wound care
Welcome to our popular Mölnlycke Talks Online - 'Covid: a catalyst to improve patient engagement. Rethink wound care'. November 23, 7:00PM CET.
October 2, 2020
Send a smile with Mölnlycke card
On World Smile Day, 2 October, in collaboration with our global charity Operation Smile, we are encouraging our employees, partners and customers to sen...
September 24, 2020
One third of surgeons and nurses experience harmful allergic reactions in the operating theatre
24 September 2020: With surgeons and nurses working to clear the elective backlog from coronavirus, a new global survey has revealed they are suffering...
Barry McBride to take on the position as interim CEO
Gothenburg – 24 July 2020 Barry McBride, EVP Gloves, Antiseptics and Global R&D, will take on the role as interim CEO as of 1 August and until the new...
June 25, 2020
AstraZeneca’s BioVentureHub and Mölnlycke collaborate to support knowledge exchange across the Swedish life science industry
AstraZeneca’s BioVentureHub announced today that it has established a new collaboration with Mölnlycke, a global medtech company headquartered in...
June 8, 2020
How we handle the Covid-19 situation
Being a provider of medical devices for health care professionals – many of which are critically needed to combat the evolving COVID-19 situation –...
May 29, 2020
Zlatko Rihter appointed new CEO of Mölnlycke
Zlatko Rihter has been appointed President and CEO of the medical solutions company, Mölnlycke Health Care AB.
April 24, 2020
Medical Device Regulation (MDR) to be postponed
The Medical Device Regulation (MDR) – which was due to enter into force in May this year –will replace the Medical Device Directive in Europe and is muc...
April 17, 2020
Mölnlycke employees volunteering at the front line
Mölnlycke takes pride in having a highly trained workforce as many of our employees have a clinical background.
April 9, 2020
Mölnlycke supplies Swedish National Board of Health and Welfare with additional 12 million face masks
By utilising its extensive global supplier network, the world-leading medical solutions company, Mölnlycke has managed to contract suppliers for...
April 4, 2020
French export ban for face masks lifted
Thanks to crucial efforts by the Swedish Prime Minister Stefan Löfven and several other parties, the French government has today decided to lift the...
March 3, 2020
CEO Richard Twomey leaves Mölnlycke
Richard Twomey, President and CEO of Mölnlycke, will after six years leave the organisation.
December 17, 2019
New cost benefit analysis reports NHS chronic wound care costs can be reduced by use of haemoglobin spray
New report shows Granulox ® (Mölnlycke), an innovative topical haemoglobin spray, is a cost-effective therapy in chronic wound care management as adjunc...
September 26, 2019
Mölnlycke appoints new Chief Financial Officer
With a strong track record of financial leadership in publicly listed Swedish companies Susanne Larsson will join the company as Group Chief Financial...
September 20, 2019
More than 9 in 10 surgeons encounter a needlestick injury
Global s urvey of 510 surgeons is first of its kind ; 81% believe high quality gloves impact patient outcomes ; 92% agree d that high...
August 29, 2019
Successful EMTN programme establishment and 10-year Eurobond issue for Mölnlycke
Mölnlycke, a world-leading medical solutions company, successfully launched on 28 August a EUR 500 million senior unsecured bond off its newly establish...
June 28, 2019
Thousands of diabetic foot ulcer patients could benefit from topical oxygen therapy with updated treatment pathway
June 25, 2019
Mölnlycke and Zuellig Pharma strengthen partnership for advanced wound care solutions in South-East Asia
The partnership will leverage deep expertise of both companies to improve range and availability of wound care products and solutions across the region
June 6, 2019
Mölnlycke acquires invention to help detect infection
How can innovation help detect wound infection and possibly reduce unnecessary use of antibiotics in wound care? Watch as R&D director Anders Dahlberg...
June 6, 2019
Mölnlycke acquires patent for smart solutions to detect infection in wounds
The Swedish medical solutions company, Mölnlycke, is acquiring a patent application from Innovation Skåne, that will help detect infections in wounds....
March 1, 2019
Introducing Healthcare Intelligence
What will healthcare look like in the next 10 years? What will it look like next year?
January 2, 2019
Mölnlycke acquires M&J Airlaid Products A/S to further strengthening its wound care capabilities
Mölnlycke, a world-leading medical products and solutions company, is pleased to announce its acquisition of M&J Airlaid Products A/S (“M&J”).
November 7, 2018
Mölnlycke at IFSO 2018 Dubai
From 26-29 September 2018, Mölnlycke was present at the 23rd World Congress of the International Federation for the Surgery of Obesity and Metabolic...
July 2, 2018
Mölnlycke acquires German wound care company SastoMed GmbH
The world-leading medical solutions company, Mölnlycke, has acquired German wound care products company, SastoMed GmbH. The deal adds new, award-winning...
December 28, 2017
Creating opportunities at AZ BioVenture Hub
Just a few months since Mölnlycke signed a partnership with AstraZeneca BioVenture Hub, and it has already resulted in collaboration and building...
July 19, 2017
Viktiga produktlanseringar under andra kvartalet
Mölnlyckes försäljning växte under årets andra kvartal med 1 % i konstant valuta. Såväl Wound Care som Surgical växte, dock med en lägre tillväxttakt än...
July 13, 2017
Mölnlycke Holding AB (publ) EUR 350,000,000 Revolving Credit Facility
We are pleased to announce the successful closing and signing of a EUR 350,000,000 Multicurrency Revolving Credit Facility (the “Facility”) for Mölnlyck...
Media & Press
Our press room
In our press room you can find the latest press releases as well as our logotype and images for download.